| Autor: |
Nathaniel R. Wilson, Michelle T. Lee, Clarence D. Gill, Astrid Serauto Canache, Teodora Donisan, Dinu V. Balanescu, Juhee Song, Nicolas Palaskas, Juan Lopez-Mattei, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cezar A. Iliescu |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Frontiers in Cardiovascular Medicine, Vol 8 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2297-055X |
| DOI: |
10.3389/fcvm.2021.638943 |
| Popis: |
Background: Pericardiocentesis is an important diagnostic and therapeutic tool for cancer-associated pericardial effusion. Limited safety and outcomes data exists regarding the management of malignancy-related pericardial effusion in patients with thrombocytopenia.Objectives: Our study aimed to analyze prognostic factors and overall survival (OS) after pericardiocentesis in thrombocytopenic cancer patients.Methods and Results: A retrospective review of 136 thrombocytopenic cancer patients who underwent primary percutaneous pericardiocentesis was performed. Degree of thrombocytopenia was classified by platelet count recorded on day of pericardiocentesis: 75–149 × 103 cells/μL (41%); 50–74 × 103 cells/μL (10%); 25–49 × 103 cells/μL (24%); |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
